» Articles » PMID: 29337387

Systematic Review of Predictive Risk Models for Adverse Drug Events in Hospitalized Patients

Overview
Specialty Pharmacology
Date 2018 Jan 17
PMID 29337387
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: An emerging approach to reducing hospital adverse drug events is the use of predictive risk scores. The aim of this systematic review was to critically appraise models developed for predicting adverse drug event risk in inpatients.

Methods: Embase, PubMed, CINAHL and Scopus databases were used to identify studies of predictive risk models for hospitalized adult inpatients. Studies had to have used multivariable logistic regression for model development, resulting in a score or rule with two or more variables, to predict the likelihood of inpatient adverse drug events. The Checklist for the critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) was used to critically appraise eligible studies.

Results: Eleven studies met the inclusion criteria and were included in the review. Ten described the development of a new model, whilst one study revalidated and updated an existing score. Studies used different definitions for outcome but were synonymous with or closely related to adverse drug events. Four studies undertook external validation, five internally validated and two studies did not validate their model. No studies evaluated impact of risk scores on patient outcomes.

Conclusion: Adverse drug event risk prediction is a complex endeavour but could help to improve patient safety and hospital resource management. Studies in this review had some limitations in their methods for model development, reporting and validation. Two studies, the BADRI and Trivalle's risk scores, used better model development and validation methods and reported reasonable performance, and so could be considered for further research.

Citing Articles

Protocol for the development and validation of a Polypharmacy Assessment Score.

Tsang J, Sperrin M, Blakeman T, Payne R, Ashcroft D Diagn Progn Res. 2024; 8(1):10.

PMID: 39010248 PMC: 11251249. DOI: 10.1186/s41512-024-00171-7.


Patients' and Clinicians' Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews.

Miller M, McCann L, Lewis L, Miaskowski C, Ream E, Darley A J Med Internet Res. 2024; 26:e49309.

PMID: 38901021 PMC: 11224704. DOI: 10.2196/49309.


Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma.

Gritti G, Belousov A, Relf J, Dixon M, Tandon M, Komanduri K Blood Adv. 2024; 8(14):3615-3618.

PMID: 38743882 PMC: 11279247. DOI: 10.1182/bloodadvances.2023011089.


Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score.

Ruiz-Ramos J, Vela E, Monterde D, Blazquez-Andion M, Puig-Campmany M, Piera-Jimenez J BMC Emerg Med. 2024; 24(1):23.

PMID: 38355411 PMC: 10865623. DOI: 10.1186/s12873-024-00946-7.


Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.

Alexander G, Budnitz D, Hughes C, Maas R, Mair A, McDonald E Drug Saf. 2023; 47(1):103-111.

PMID: 37917316 DOI: 10.1007/s40264-023-01362-9.


References
1.
Sakuma M, Bates D, Morimoto T . Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study. Pharmacoepidemiol Drug Saf. 2012; 21(11):1221-6. DOI: 10.1002/pds.3331. View

2.
Mueller S, Sponsler K, Kripalani S, Schnipper J . Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012; 172(14):1057-69. PMC: 3575731. DOI: 10.1001/archinternmed.2012.2246. View

3.
Hakkarainen K, Hedna K, Petzold M, Hagg S . Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis. PLoS One. 2012; 7(3):e33236. PMC: 3305295. DOI: 10.1371/journal.pone.0033236. View

4.
Davies E, Green C, Taylor S, Williamson P, Mottram D, Pirmohamed M . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4(2):e4439. PMC: 2635959. DOI: 10.1371/journal.pone.0004439. View

5.
Mallett S, Royston P, Dutton S, Waters R, Altman D . Reporting methods in studies developing prognostic models in cancer: a review. BMC Med. 2010; 8:20. PMC: 2856521. DOI: 10.1186/1741-7015-8-20. View